ecancer

Editor's Choice for June 2018

Prof Gordon McVie - Founding Editor, ecancer

4 Jul 2018

ASCO 2018 conference round up

Dr Bishal Gyawali and Will Davies

24 Jun 2018

Results from the phase I ICONIC trial

Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA

4 Jun 2018

Economic impact of NGS in non small cell lung cancer

Dr Nathan Pennell - Cleveland Clinic Cancer Center, Cleveland, USA

4 Jun 2018

Avelumab in combinations for lung cancer and update from ALEX study

Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA

4 Jun 2018

Early results from a 3rd gen EGFR-TKI in advanced NSCLC

Prof Byoung Chul Cho - Yonsei Cancer Center, Seoul, the Republic of Korea

3 Jun 2018

Pembrolizumab works better than chemotherapy alone as initial treatment for NSCLC

Dr Gilberto Lopes - Sylvester Comprehensive Cancer Center, Miami, USA

3 Jun 2018

Comment: PD-1 immunotherapy better than chemo alone as first line lung cancer treatment

Dr John Heymach & Prof Richard Schilsky

3 Jun 2018

PD-1 immunotherapy better than chemo alone as first line lung cancer treatment

Dr Gilberto Lopes - Oncoclinicas do Brasil, São Paulo, Brazil

3 Jun 2018

Web-mediated follow-up via patient-reported outcomes vs. routine surveillance in lung cancer patients

Dr Fabrice Denis - Jean Bernard Centre, Le Mans, France

2 Jun 2018

Development of blood tests for early lung cancer

Dr Geoffrey Oxnard - Dana-Farber Cancer Institute, Boston, USA

2 Jun 2018

Atezolizumab with chemotherapy improves PFS in squamous NSCLC

Dr Robert Jotte - Rocky Mountain Cancer Centers, Denver, USA

2 Jun 2018

More from ecancer